On April 27, "Meds Health," an investee company of Qiming Venture Partners—a sub-fund backed by the mother fund managed by Yuanhe Chukun—was listed on the Main Board of the Hong Kong Stock Exchange, with stock code: 2415.HK.

Founded in 2012, Meis Health is one of China's largest and most active professional physician service platforms. It uses big data and artificial intelligence technologies to connect doctors, patients, pharmaceutical and medical device companies, providing precise digital medical communication solutions that empower the healthcare ecosystem and improve medical quality. Currently, Meis Health mainly offers clients physician platform solutions, precise omni-channel marketing solutions, and RWS solutions, covering areas such as clinical research, physician career development, and multi-channel academic communication.

As of the end of 2022, the Meis Health platform boasted approximately 2.9 million registered physician users, with an average of about 2.7 million monthly active users throughout 2022. Additionally, the Meis Medical platform features a high proportion of senior physicians holding titles such as associate chief physicians and above—around 530,000 registered physicians at the associate chief and chief levels, accounting for roughly 68.8% of all associate and chief physicians in China. Both the total number of registered users and the number of active users place Meis Health firmly at the industry’s top position.

China's medical market, as well as its pharmaceutical and medical device sectors, boasts vast growth potential and is currently undergoing a transformative digital evolution. Against this backdrop, China's physician platform services market is rapidly expanding, creating numerous new opportunities for industry players—and providing fertile ground for Mays Health to achieve long-term, rapid, and sustainable growth. Leveraging its robust physician network, platform strengths, exceptional academic expertise, and cutting-edge digital technologies, Mays Health has built a formidable core competitive edge in its omnichannel marketing business, positioning itself as the go-to digital marketing platform of choice for commercializing innovative drugs and medical devices.